2024年

英文

1. Togawa K, Fong GT, Quah ACK, Meng G, Xu SS, Quimet J, Mochizuki Y, Yoshimi I, Odani S, Tabuchi T, Katanoda K. Impacts of revised smoke-free regulations under the 2020 Japan Health Promotion Act on cigarette smoking and heated tobacco product use in indoor public places and homes: findings from 2018 to 2021 International Tobacco Control (ITC) Japan Surveys. Tob Control. 2024 Oct 17:tc-2024-058697. [PubMed]
2. Sato A, Tanaka H, Tabuchi T, Katanoda K. Occupational differences in SARS-CoV-2 infection: the Japan COVID-19 and Society Internet Survey (JACSIS) study in 2022. BMC Public Health. 2024;24(1):2841. Published 2024 Oct 16.[PubMed]
3. Momosaka T, Saito J, Otsuki A, Yaguchi-Saito A, Fujimori M, Kuchiba A, Katanoda K, Takaku R, Shimazu T. Associations of Individual Characteristics and Socioeconomic Status With Heated Tobacco Product Harmfulness Perceptions in Japan: A Nationwide Cross-sectional Study (INFORM Study 2020). J Epidemiol. 2024 Sep 5;34(9):411-418. [PubMed]
4. Ota M, Taniguchi K, Hori M, Katanoda K, Nakata K, Miyashiro I, Matsuda T, Lee SW, Ito Y. Trends in patterns of treatment and survival of colorectal cancer patients using cancer registry data in Japan: 1995-2015. Cancer Sci. 2024 Aug;115(8):2786-2794.[PubMed]
5. Miura M, Tabuchi T, Amano H, Katanoda K. Evaluation of the Association Between Sedentary Time and Low Work Engagement in the Work Environment After COVID-19 Pandemic: A Cross-Sectional Study of Japanese Workers. Cureus. 2024 Jun 19;16(6):e62725.[PubMed]
6. Kim J, Macharia PM, McCormack V, Foerster M, Galukande M, Joffe M, Cubasch H, Zietsman A, Anele A, Offiah S, Parham G, Pinder LF, Anderson BO, Schüz J, Dos Santos-Silva I, Togawa K. Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study. Lancet Glob Health. 2024 Jul;12(7):e1111-e1119.  [PubMed]
7. Ong SK, Abe SK, Gek Phua GL, Jayasekara H, Togawa K, Gatellier L, Kim J, Zhang Y, Kahan SZ, Yusof SN, Han JS, Pramesh CS, Sengar M, Shankar A, Cairo C, Sangrajran S, Nansalmaa E, Badamsuren T, Dendup T, Tshering K, He J, Werdi Nindito D RS, Ritana A, Im JS, Park EY, Huong GN, Thanh Huong TT, Biglari M, Yusuf A, Pradhananga KK, Vongdala C, Bin Jaafar MT, Ibrahim Tamin NS, Myint YY, Kaung KK, Rahman MS, Fernando E, Rath B, Sukumaran B, Hwang WY, Espina C, Schüz J, Inoue M, Matsuda T. Mapping recommendations towards an Asian Code Against Cancer (ACAC) as part of the World Code Against Cancer Framework: an Asian National Cancer Centers Alliance (ANCCA) initiative. Lancet Reg Health Southeast Asia. 2024 May 22;24:100316.[PubMed]
8. Kyriakos CN, Erinoso O, Driezen P, Thrasher JF, Katanoda K, Quah ACK, Tabuchi T, Perez CA, Seo HG, Kim SY, Nordin ASA, Hairi FM, Fong GT, Filippidis FT. Prevalence and perceptions of flavour capsule cigarettes among adults who smoke in Brazil, Japan, Republic of Korea, Malaysia and Mexico: findings from the ITC surveys. BMJ Open. 2024 Apr 19;14(4):e083080.[PubMed]
9. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K. Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan. Tob Control. 2024 Apr 19;33(3):295-301.[PubMed]
10. Tanaka H, Katanoda K, Togawa K, Kobayashi Y. Educational inequalities in all-cause and cause-specific mortality in Japan: national census-linked mortality data for 2010-15. Int J Epidemiol. 2024;53(2):dyae031.[PubMed]
    【研究内容の紹介】→ [詳細はこちら（研究トピックス）]
11. Palmer MR, Saito E, Katanoda K, Sakamoto H, Hocking JS, Brotherton JML, Ong JJ. The impact of alternate HPV vaccination and cervical screening strategies in Japan: a cost-effectiveness analysis. Lancet Reg Health West Pac. 2024 Feb 19;44:101018.[PubMed]
12. Tsuge H, Kawakita D, Taniyama Y, Oze I, Koyanagi YN, Hori M, Nakata K, Sugiyama H, Miyashiro I, Oki I, Nishino Y, Katanoda K, Ito Y, Shibata A, Matsuda T, Iwasaki S, Matsuo K, Ito H. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study. Cancer Sci. 2024;115(2):623-634.[PubMed]

和文

1. 片野田 耕太.　わが国のがんサバイバーの現状―統計データから ：臨床栄養 145(5) 576-581, 2024
2. 岩瀬 絵里奈, 大和 浩, 田淵 貴大, 十川 佳代, 片野田 耕太, 中村 正和．喫煙者における文字のみおよび画像付きタバコパッケージの警告表示への認識に関する横断分析：日本公衆衛生学雑誌,71(12) 756-765, 2024.[J-STAGE]
3. 片野田 耕太.　特集 女性のライフコース疫学研究「日本ナースヘルス研究（JNHS）」のすべて ：出生時体重,若年時体型と2型糖尿病：産科と婦人科,91(5)507-513, 2024
4. 片野田 耕太, 道林 千賀子, 齋藤 順子, 島津 太一, 中村 正和． たばこ対策のロジックモデルとアクションプランの例―受動喫煙対策― ：日本健康教育学会誌, 32(Special_issue)  S121-S130, 2024.[J-STAGE]
5. 齋藤 順子, 島津 太一, 片野田 耕太, 道林 千賀子, 中村 正和.　たばこ対策のロジックモデルとアクションプランの例―職域のたばこ対策―：日本健康教育学会誌, 32(Special_issue)　S112-S120, 2024.[J-STAGE]
6. 道林 千賀子, 片野田 耕太, 齋藤 順子, 島津 太一, 中村 正和.　たばこ対策のロジックモデルとアクションプランの例―成人・妊婦の喫煙率減少―：日本健康教育学会誌, 32(Special_issue)  S102-S111, 2024.[J-STAGE]
7. 中村 正和, 片野田 耕太, 道林 千賀子, 齋藤 順子, 島津 太一.　たばこ対策のロジックモデルとアクションプラン（総論）：日本健康教育学会誌, 32(Special_issue)  S94-S101, 2024.[J-STAGE]
8. 片野田 耕太, 十川 佳代, 中村 正和. 「たばこハームリダクション」は可能か？：国際的動向と日本での論点：日本公衆衛生学雑誌, 71(3) 141-152, 2024.[J-STAGE]